Abstract:Simple summary: Studies have shown that about 30% of kidney cancer patients will have metastasis, and lymph node metastasis (LNM) may be related to a poor prognosis. Our retrospective study aims to provide a reliable machine learning-based model to predict the occurrence of LNM in kidney cancer. We screened the pathological grade, liver metastasis, M staging, primary site, T staging, and tumor size from the training group (n=39016) formed by the SEER database and the validation group (n=771) formed by the medical center. Independent predictors of LNM in cancer patients. Using six different algorithms to build a prediction model, it is found that the prediction performance of the XGB model in the training group and the validation group is significantly better than any other machine learning model. The results show that prediction tools based on machine learning can accurately predict the probability of LNM in patients with kidney cancer and have satisfactory clinical application prospects. Background: Lymph node metastasis (LNM) is associated with the prognosis of patients with kidney cancer. This study aimed to provide reliable machine learning-based (ML-based) models to predict the probability of LNM in kidney cancer. Methods: Data on patients diagnosed with kidney cancer were extracted from the Surveillance, Epidemiology and Outcomes (SEER) database from 2010 to 2017, and variables were filtered by least absolute shrinkage and selection operator (LASSO), univariate and multivariate logistic regression analyses. Statistically significant risk factors were used to build predictive models. We used 10-fold cross-validation in the validation of the model. The area under the receiver operating characteristic curve (AUC) was used to assess the performance of the model. Correlation heat maps were used to investigate the correlation of features using permutation analysis to assess the importance of predictors. Probability density functions (PDFs) and clinical utility curves (CUCs) were used to determine clinical utility thresholds. Results: The training cohort of this study included 39,016 patients, and the validation cohort included 771 patients. In the two cohorts, 2544 (6.5%) and 66 (8.1%) patients had LNM, respectively. Pathological grade, liver metastasis, M stage, primary site, T stage, and tumor size were independent predictive factors of LNM. In both model validation, the XGB model significantly outperformed any of the machine learning models with an AUC value of 0.916.A web calculator (https://share.streamlit.io/liuwencai4/renal_lnm/main/renal_lnm.py) were built based on the XGB model. Based on the PDF and CUC, we suggested 54.6% as a threshold probability for guiding the diagnosis of LNM, which could distinguish about 89% of LNM patients. Conclusions: The predictive tool based on machine learning can precisely indicate the probability of LNM in kidney cancer patients and has a satisfying application prospect in clinical practice.

Deep learning-based pathological prediction of lymph node metastasis for patient with renal cell carcinoma from primary whole slide images

Deep learning-based diagnosis and survival prediction of patients with renal cell carcinoma from primary whole slide images

A deep learning method for predicting the origins of cervical lymph node metastatic cancer on digital pathological images

Classifying Subtypes and Predicting Survival of Renal Cell Carcinoma Using Histopathology Image-Based Deep Learning

Predicting Lymph Node Metastasis from Primary Cervical Squamous Cell Carcinoma Based on Deep Learning in Histopathologic Images.

Cervical Cancer Metastasis and Recurrence Risk Prediction Based on Deep Convolutional Neural Network

Prediction of lymph node metastasis in primary gastric cancer from pathological images and clinical data by multimodal multiscale deep learning

A Precision Diagnostic Framework of Renal Cell Carcinoma on Whole-Slide Images using Deep Learning.

Predicting Metastasis Risk in Pancreatic Neuroendocrine Tumors Using Deep Learning Image Analysis

Deep learning system for lymph node quantification and metastatic cancer identification from whole-slide pathology images

Predicting Gastric Cancer Outcome from Resected Lymph Node Histopathology Images Using Deep Learning.

Evaluation of a Deep Learning Model for Metastatic Squamous Cell Carcinoma Prediction From Whole Slide Images

Deep learning approach for predicting lymph node metastasis in non-small cell lung cancer by fusing image–gene data

Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning

A novel model for predicting postoperative liver metastasis in R0 resected pancreatic neuroendocrine tumors: integrating computational pathology and deep learning-radiomics

Identification of lymph node metastasis in pre‐operation cervical cancer patients by weakly supervised deep learning from histopathological whole‐slide biopsy images

Abstract 896: Predicting metastatic transcriptomes of patient tumors with deep learning

A deep learning model for lymph node metastasis prediction based on digital histopathological images of primary endometrial cancer

Development and validation of a machine learning model to predict the risk of lymph node metastasis in renal carcinoma

Application of artificial intelligence model in pathological staging and prognosis of clear cell renal cell carcinoma

Clinical Use of a Machine Learning Histopathological Image Signature in Diagnosis and Survival Prediction of Clear Cell Renal Cell Carcinoma.